IFP Advisors, Inc - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 109 filers reported holding ANTARES PHARMA INC in Q4 2017. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2022$12,0000.0%4,3690.0%0.00%
Q2 2022$12,000
-33.3%
4,369
-35.2%
0.00%
Q1 2022$18,000
+157.1%
6,738
+236.9%
0.00%
Q4 2021$7,000
-46.2%
2,000
-46.2%
0.00%
Q3 2021$13,000
+8.3%
3,715
+25.3%
0.00%
Q2 2021$12,0000.0%2,9650.0%0.00%
Q1 2021$12,000
+71.4%
2,965
+72.9%
0.00%
Q4 2020$7,000
+40.0%
1,7150.0%0.00%
Q3 2020$5,0000.0%1,7150.0%0.00%
Q2 2020$5,000
-54.5%
1,715
-63.6%
0.00%
-100.0%
Q1 2020$11,000
-50.0%
4,7150.0%0.00%
-50.0%
Q4 2019$22,000
-80.2%
4,715
-85.6%
0.00%
-71.4%
Q3 2019$111,00032,715
+34336.8%
0.01%
Q1 2019$0
-100.0%
95
-99.7%
0.00%
-100.0%
Q4 2018$85,000
-64.9%
32,445
-55.0%
0.01%
-50.0%
Q3 2018$242,000
+64.6%
72,165
+26.5%
0.01%
+66.7%
Q2 2018$147,00057,027
+59928.4%
0.01%
Q1 2018$0950.0%0.00%
Q4 2017$0
-100.0%
95
-99.3%
0.00%
-100.0%
Q3 2017$46,000
+2.2%
14,0950.0%0.00%0.0%
Q2 2017$45,000
+12.5%
14,0950.0%0.00%0.0%
Q1 2017$40,000
+21.2%
14,0950.0%0.00%0.0%
Q4 2016$33,000
+37.5%
14,0950.0%0.00%
+100.0%
Q3 2016$24,000
+60.0%
14,0950.0%0.00%0.0%
Q2 2016$15,00014,095
+14736.8%
0.00%
Q1 2016$0
-100.0%
95
-99.3%
0.00%
-100.0%
Q4 2015$17,00014,0950.00%
Other shareholders
ANTARES PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 3,096,355$8,422,0005.18%
JW Asset Management, LLC 1,920,524$5,224,0003.85%
Healthcare Value Capital, LLC 250,000$680,0002.64%
ARMISTICE CAPITAL, LLC 10,300,000$28,016,0002.12%
Broadfin Capital, LLC 3,444,147$9,368,0001.23%
PERKINS CAPITAL MANAGEMENT INC 409,000$1,112,0000.86%
MYCIO WEALTH PARTNERS, LLC 1,896,500$5,158,0000.48%
ESSEX INVESTMENT MANAGEMENT CO LLC 1,012,600$2,754,0000.22%
FALCON POINT CAPITAL, LLC 130,200$354,0000.21%
Brown Advisory Securities, LLC 275,000$781,0000.15%
View complete list of ANTARES PHARMA INC shareholders